• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

MRI-Guided Brain Zaps Ease Severe Depression for 6 Months

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 16, 2024.

By Dennis Thompson HealthDay Reporter

TUESDAY, Jan. 16, 2024 -- Magnetic zaps to the brain can significantly help people with severe depression, if the procedure is guided using MRI brain scans, a new clinical trial has concluded.

On average, patients showed substantial improvements in depression, anxiety, cognition and quality of life for at least six months after undergoing MRI-guided transcranial magnetic stimulation (TMS), results show.

One-third experienced a 50% improvement in symptoms, while one-fifth managed to go into remission and remain there.

“Given these patients are people who have not responded to two previous treatment attempts and have been ill for an average of 7 years, to get such a significant response rate and a fifth who have a sustained response is really encouraging,” said researcher Richard Morriss, lead for the Center for Mood Disorders at the University of Nottingham’s Institute of Mental Health in the U.K..

TMS is a noninvasive outpatient treatment in which powerful magnetic impulses are delivered to the left side of a person’s head while they are conscious.

The method has been used since the 1980s to treat severe depression in people who don’t respond to antidepressants or therapy, researchers said.

However, the benefits of TMS have so far proven fleeting, tending to last just one to three months, researchers explained in background notes.

In this clinical trial, investigators examined whether better targeting of the magnetic pulses could provide longer-lasting benefits to people with depression.

For this study, researchers recruited 255 people with treatment-resistant depression and had them complete a total of 20 TMS sessions.

Patients received TMS guided by both MRI and “neuronavigation,” a computerized tracking system that helped researchers precisely target the brain region to receive stimulation.

“The MRI personalizes the site of stimulation and then neuronavigation makes sure the same site is being stimulated at each treatment session,” Morriss explained in a university news release. “This reduces the variability in stimulation at each session.”

The new study was published Jan. 16 in the journal Nature Medicine.

Given these results, it’s possible that patients receiving TMS could only require one or two courses of treatment each year to remain relatively free from symptoms of depression, Morriss concluded.

“The changes we saw were substantial, not only in reducing their depression symptoms, but they were large enough to improve concentration, memory, anxiety and subsequently their quality of life,” Morriss said.

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.